Increased Circulating Levels of Vitamin D Binding Protein in MS Patients

Vitamin D-binding protein controls T cell responses to vitamin D

(2014) Martin Kongsbak et al.   BMC IMMUNOLOGY

Assessing Vitamin D Status: Time for a Rethink?

(2014) G. D. Carter et al.   CLINICAL CHEMISTRY

Vitamin D supplementation in pregnancy: a systematic review

(2014) Nicholas C Harvey et al.   HEALTH TECHNOLOGY ASSESSMENT

Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression

(2014) Alberto Ascherio et al.   JAMA Neurology

Vitamin D and DBP: The free hormone hypothesis revisited

(2013) Rene F. Chun et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression

(2013) Mingchong Yang et al.   MOLECULAR NEUROBIOLOGY

Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis

(2013) Joost Smolders et al.   Multiple Sclerosis Journal

The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis

(2013) Eleanor James et al.   Multiple Sclerosis Journal

Vitamin D–Binding Protein and Vitamin D Status of Black Americans and White Americans

(2013) Camille E. Powe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vitamin D and multiple sclerosis

(2012) Kelly C. Simon et al.   CURRENT OPINION IN NEUROLOGY

Availability of 25-Hydroxyvitamin D3 to APCs Controls the Balance between Regulatory and Inflammatory T Cell Responses

(2012) L. E. Jeffery et al.   JOURNAL OF IMMUNOLOGY

Vitamin D and disease activity in multiple sclerosis before and during interferon-  treatment

(2012) K. I. Loken-Amsrud et al.   NEUROLOGY

Interferon-  and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS

(2012) N. Stewart et al.   NEUROLOGY

Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis

(2012) T. F. Runia et al.   NEUROLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Vitamin D in the healthy and inflamed central nervous system: access and function

(2011) Joost Smolders et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Prevention and treatment of MS: studying the effects of vitamin D

(2011) Kassandra L Munger et al.   Multiple Sclerosis Journal

Hypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosis

(2010) Alina Kułakowska et al.   BMC Neurology

Vitamin D-Binding Protein Directs Monocyte Responses to 25-Hydroxy- and 1,25-Dihydroxyvitamin D

(2010) Rene F. Chun et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Gender Differences in 1,25 Dihydroxyvitamin D3 Immunomodulatory Effects in Multiple Sclerosis Patients and Healthy Subjects

(2010) J. Correale et al.   JOURNAL OF IMMUNOLOGY

The emerging role of vitamin D binding protein in multiple sclerosis

(2010) Giulio Disanto et al.   JOURNAL OF NEUROLOGY

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

(2010) Sreeram V Ramagopalan et al.   LANCET NEUROLOGY

Protein expression profiles in pediatric multiple sclerosis: potential biomarkers

(2009) KN Rithidech et al.   Multiple Sclerosis Journal

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

(2008) J Smolders et al.   Multiple Sclerosis Journal

A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis

(2007) M Soilu-Hanninen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY